SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-22-008922
Filing Date
2022-08-19
Accepted
2022-08-19 16:06:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT tnxp-s3_081922.htm S-3 286663
2 REGISTRATION FEE ex-filingfees.htm EX-FILING FEES 10131
3 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP. ex5-01.htm EX-5.01 18765
4 OPINION OF LOWENSTEIN SANDLER, LLP ex5-02.htm EX-5.02 15356
5 CONSENT OF EISNERAMPER LLP. ex23-01.htm EX-23.01 3292
6 GRAPHIC ex5-2_img001.jpg GRAPHIC 3957
7 GRAPHIC ex5-2_img002.jpg GRAPHIC 7506
8 GRAPHIC tnxp001.jpg GRAPHIC 16658
9 GRAPHIC ex5-01_01.jpg GRAPHIC 3719
  Complete submission text file 0001387131-22-008922.txt   379665
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266982 | Film No.: 221180812
SIC: 2834 Pharmaceutical Preparations